Earnings Update: Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson reported Q1 earnings per share of $1.56, which was above the FactSet estimate for $1.53.
Revenues for the quarter were reported at $17.37 billion, which was above the estimate of $17.31 billion.
The company guided Full Year EPS to a range of $6.04-6.19 vs prior guidance $6.12-6.27 and FactSet $6.19 .
“The company delivered strong underlying growth in the first quarter driven by new products and the strength of the core business. Of note is the continued robust growth of the Pharmaceutical business and the solid performance of our Consumer brands,” said Alex Gorsky, Chairman and Chief Executive Officer. “I am proud of our global teams who focus every day on delivering innovative solutions to address evolving health care needs.
Shares of JNJ last traded at $100.85, which is up slightly from the last closing price of $100.55.
Check out the SmartMix ® Strategy
Keeping Clients Focused on the Right Strategy at the Right Time
Performance Update: +10.0% in 2014
+393% from 2008 strategy inception
Fact Sheets Available on Website
Remember, you are in control your email alerts! You can receive alerts for more than 20 free research report alerts including: The “10.0” Report, The Insiders Report, ETF Leaders Report, and The Focus List.